{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-165676","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2022-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.883785+00:00","generated_at":"2026-06-25T05:01:28.039710+00:00","sec_items":["7.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Anthem reaffirms FY 2022 adjusted net income >$28.40/share","bullets":["Full-year 2022 net income guidance >$26.43 per share, including ~$1.97/share net unfavorable items.","Excluding unfavorable items, adjusted net income expected >$28.40 per share.","Guidance excludes adjustments beyond those reported in Q1 2022 earnings release.","Officers will speak with investors over the next several weeks, reaffirming this outlook."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-165676","json":"https://secwatch.observer/filing/0001193125-22-165676.json","markdown":"https://secwatch.observer/filing/0001193125-22-165676.md","text":"https://secwatch.observer/filing/0001193125-22-165676.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000119312522165676/0001193125-22-165676-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000119312522165676/d358893d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T05:01:28.039710+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}